Literature DB >> 26615023

Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons.

Phillip H Beske1, Aaron B Bradford1, Justin O Grynovicki1, Elliot J Glotfelty1, Katie M Hoffman1, Kyle S Hubbard1, Kaylie M Tuznik1, Patrick M McNutt2.   

Abstract

Clinical manifestations of tetanus and botulism result from an intricate series of interactions between clostridial neurotoxins (CNTs) and nerve terminal proteins that ultimately cause proteolytic cleavage of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins and functional blockade of neurotransmitter release. Although detection of cleaved SNARE proteins is routinely used as a molecular readout of CNT intoxication in cultured cells, impaired synaptic function is the pathophysiological basis of clinical disease. Work in our laboratory has suggested that the blockade of synaptic neurotransmission in networked neuron cultures offers a phenotypic readout of CNT intoxication that more closely replicates the functional endpoint of clinical disease. Here, we explore the value of measuring spontaneous neurotransmission frequencies as novel and functionally relevant readouts of CNT intoxication. The generalizability of this approach was confirmed in primary neuron cultures as well as human and mouse stem cell-derived neurons exposed to botulinum neurotoxin serotypes A-G and tetanus neurotoxin. The sensitivity and specificity of synaptic activity as a reporter of intoxication was evaluated in assays representing the principal clinical and research purposes of in vivo studies. Our findings confirm that synaptic activity offers a novel and functionally relevant readout for the in vitro characterizations of CNTs. They further suggest that the analysis of synaptic activity in neuronal cell cultures can serve as a surrogate for neuromuscular paralysis in the mouse lethal assay, and therefore is expected to significantly reduce the need for terminal animal use in toxin studies and facilitate identification of candidate therapeutics in cell-based screening assays. Published by Oxford University Press on behalf of the Society of Toxicology 2015. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  botulinum toxins; electrophysiology; neurons; spontaneous postsynaptic currents; synaptic transmission; tetanus toxin

Mesh:

Substances:

Year:  2015        PMID: 26615023      PMCID: PMC4751230          DOI: 10.1093/toxsci/kfv254

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  46 in total

Review 1.  Botulinum neurotoxin: a marvel of protein design.

Authors:  Mauricio Montal
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  Quantitative ultrastructural analysis of hippocampal excitatory synapses.

Authors:  T Schikorski; C F Stevens
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Cultures of cerebellar granule neurons.

Authors:  Parizad M Bilimoria; Azad Bonni
Journal:  CSH Protoc       Date:  2008-12-01

Review 5.  Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.

Authors:  G Schiavo; O Rossetto; C Montecucco
Journal:  Semin Cell Biol       Date:  1994-08

6.  SNAP receptors implicated in vesicle targeting and fusion.

Authors:  T Söllner; S W Whiteheart; M Brunner; H Erdjument-Bromage; S Geromanos; P Tempst; J E Rothman
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

Review 7.  Are unreliable release mechanisms conserved from NMJ to CNS?

Authors:  Tyler B Tarr; Markus Dittrich; Stephen D Meriney
Journal:  Trends Neurosci       Date:  2012-10-25       Impact factor: 13.837

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

10.  Functional evaluation of biological neurotoxins in networked cultures of stem cell-derived central nervous system neurons.

Authors:  Kyle Hubbard; Phillip Beske; Megan Lyman; Patrick McNutt
Journal:  J Vis Exp       Date:  2015-02-05       Impact factor: 1.355

View more
  11 in total

1.  Neuronal delivery of antibodies has therapeutic effects in animal models of botulism.

Authors:  Patrick M McNutt; Edwin J Vazquez-Cintron; Luis Tenezaca; Celinia A Ondeck; Kyle E Kelly; Mark Mangkhalakhili; James B Machamer; Christopher A Angeles; Elliot J Glotfelty; Jaclyn Cika; Cesar H Benjumea; Justin T Whitfield; Philip A Band; Charles B Shoemaker; Konstantin Ichtchenko
Journal:  Sci Transl Med       Date:  2021-01-06       Impact factor: 17.956

2.  Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes.

Authors:  Jean Mukherjee; Celinia A Ondeck; Jacqueline M Tremblay; Jacob Archer; Michelle Debatis; Alexa Foss; Junya Awata; Jesse H Erasmus; Patrick M McNutt; Charles B Shoemaker
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

3.  Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.

Authors:  James B Machamer; Edwin J Vazquez-Cintron; Sean W O'Brien; Kyle E Kelly; Amber C Altvater; Kathleen T Pagarigan; Parker B Dubee; Celinia A Ondeck; Patrick M McNutt
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

4.  Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.

Authors:  Edwin J Vazquez-Cintron; Phillip H Beske; Luis Tenezaca; Bao Q Tran; Jonathan M Oyler; Elliot J Glotfelty; Christopher A Angeles; Aurelia Syngkon; Jean Mukherjee; Suzanne R Kalb; Philip A Band; Patrick M McNutt; Charles B Shoemaker; Konstantin Ichtchenko
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

5.  Embryonic Stem Cell-Derived Neurons Grown on Multi-Electrode Arrays as a Novel In vitro Bioassay for the Detection of Clostridium botulinum Neurotoxins.

Authors:  Stephen P Jenkinson; Denis Grandgirard; Martina Heidemann; Anne Tscherter; Marc-André Avondet; Stephen L Leib
Journal:  Front Pharmacol       Date:  2017-02-23       Impact factor: 5.810

Review 6.  Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance.

Authors:  Nagarajan Thirunavukkarasu; Eric Johnson; Segaran Pillai; David Hodge; Larry Stanker; Travis Wentz; BalRam Singh; Kodumudi Venkateswaran; Patrick McNutt; Michael Adler; Eric Brown; Thomas Hammack; Donald Burr; Shashi Sharma
Journal:  Front Bioeng Biotechnol       Date:  2018-06-22

7.  iPSC-derived myelinoids to study myelin biology of humans.

Authors:  Owen G James; Bhuvaneish T Selvaraj; Dario Magnani; Karen Burr; Peter Connick; Samantha K Barton; Navneet A Vasistha; David W Hampton; David Story; Robert Smigiel; Rafal Ploski; Peter J Brophy; Charles Ffrench-Constant; David A Lyons; Siddharthan Chandran
Journal:  Dev Cell       Date:  2021-05-03       Impact factor: 12.270

8.  Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1.

Authors:  Maren Schenke; Hélène-Christine Prause; Wiebke Bergforth; Adina Przykopanski; Andreas Rummel; Frank Klawonn; Bettina Seeger
Journal:  Toxins (Basel)       Date:  2021-08-22       Impact factor: 4.546

9.  Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.

Authors:  Phillip H Beske; Katie M Hoffman; James B Machamer; Margaret R Eisen; Patrick M McNutt
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

10.  Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.

Authors:  Jacqueline M Tremblay; Edwin Vazquez-Cintron; Kwok-Ho Lam; Jean Mukherjee; Daniela Bedenice; Celinia A Ondeck; Matthieu T Conroy; Skylar M L Bodt; Brittany M Winner; Robert P Webb; Konstantin Ichtchenko; Rongsheng Jin; Patrick M McNutt; Charles B Shoemaker
Journal:  Toxins (Basel)       Date:  2020-09-24       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.